Patents by Inventor René Beerli

René Beerli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline derivatives which promote the release of parathyroid hormone
    Patent number: 8476286
    Abstract: Use of compound of formula (I), wherein, is, or, and wherein the symbols are as defined, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, for the preparation of a medicament for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: July 2, 2013
    Assignee: Novartis AG
    Inventors: René Beerli, Ruben A Tommasi, Sven Weiler, Leo Widler
  • Covalently immobilized fluoroionophores for optical ion sensors
    Patent number: 6294390
    Abstract: Compounds, constructed in modular manner, of formula (I), wherein I is the monovalent residue of an ionophore, F is the monovalent residue of a fluorophore, G is a functional group, T is a trivalent organic radical and R01, R02 and R03 are each independently of the others a direct bond or a bridging group. The compounds may be used in immobilized form as active components in polymer membranes of optical sensors for the detection of ions. The sensors are distinguished by a long usable life and a high degree of sensitivity.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: September 25, 2001
    Assignee: Novartis Ag
    Inventors: Steven Mark Barnard, René Beerli, Joseph Berger, David Reinhoudt, Adrian Waldner
  • Sensors
    Patent number: 6245574
    Abstract: Sensors for the qualitative and quantitative determination of K+ ions in aqueous systems are described, which consist essentially of a carrier and an active layer applied to this carrier, whereby the active layer contains a polymer in which is dispersed at least one modified valinomycin, in which a radical of a fluorescence dye which emits in long waves, preferably an acridine or fluorescein, with an emission wave length of >550, is covalently bound.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: June 12, 2001
    Assignee: Novartis AG
    Inventors: Adrian Waldner, René Beerli, Steven Mark Barnard